Non-opioid pain medicine after vaginal pelvic surgery
Treatments studied
Part of Kidney & urinary, Pain, Women’s health & pregnancy clinical trials.
This study tests a new non-opioid pain medicine called suzetrigine to see if it can control pain after vaginal pelvic surgery while reducing the need for opioid painkillers. If you are having this type of surgery soon, this trial might offer you an alternative for pain management.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are having elective vaginal pelvic reconstructive surgery at UCLA and will either go home the same day or stay for up to 23 hours.
- You are not currently taking opioid pain medications on a regular basis.
- You do not have severe liver failure, end-stage kidney disease, or chronic pain conditions like fibromyalgia or chronic pelvic pain.
- You are able to take acetaminophen (Tylenol) and ibuprofen (Advil/Motrin).
- You have not used certain medications (strong CYP3A4 inhibitors) within 7 days before surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new non-opioid pain medicine called suzetrigine for pain after certain types of pelvic surgery. If it works, it might help you recover with fewer side effects than opioids.
This study tests whether adding suzetrigine to standard pain relief improves recovery after minimally invasive hysterectomy. Suzetrigine is a new type of painkiller that may reduce the need for opioids.
This study tests a non-opioid pain medicine called suzetrigine (also known as Journavx) to see how well it controls pain after lower back surgery. It might be a good option if you're having lumbar fusion surgery and want to avoid the side effects of opioid painkillers.
This study tests a new non-opioid pain medicine called suzetrigine to see how well it controls pain after ankle replacement surgery. The goal is to manage pain with fewer opioid-related side effects.
This study tests a new pain medicine, suzetrigine, to see if it can reduce the need for opioids after a tonsillectomy or similar throat surgery. It aims to provide effective pain control with fewer opioid-related risks.
This trial tests a new painkiller called suzetrigine for post-surgery pain. It's designed for people whose medical records suggest they may have a higher chance of needing strong painkillers (opioids) long after surgery. We want to see if suzetrigine works better at preventing that.
Hear when a new Postoperative Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.